Hemophilia patients across Syria’s provinces have issued an urgent appeal to the Ministry of Health and other relevant authorities, calling for immediate action to secure the essential medications required to keep them alive.

Mounting Risk of Fatal Hemorrhages

Patients suffering from this rare genetic disorder face severe obstacles in obtaining the clotting factors needed to stop internal bleeding and prevent life-threatening complications. Physicians and patient advocates warn that any interruption in the supply of these therapies exposes individuals to sudden hemorrhages, permanent physical damage and potentially fatal outcomes.

Appeal for Reliable and Free Access to Treatment

Patients stress that their demands reflect basic rights to healthcare and dignity. Their foremost request is the guaranteed, uninterrupted delivery of hemophilia medications to hospitals and clinics across all Syrian provinces. They also urge authorities to reinstate free distribution of these treatments in public facilities, a measure they say is essential to easing the overwhelming financial burden currently borne by families.

This article was translated and edited by The Syrian Observer. The Syrian Observer has not verified the content of this story. Responsibility for the information and views set out in this article lies entirely with the author.

The post Syrian Hemophilia Patients Issue Urgent Appeal Over Critical Shortage of Life-Saving Medications first appeared on The Syrian Observer.